AboutPortfolioInvestment FocusLeadershipInsightsContact Partner With Us
Private Capital & Strategic Partnerships

Investing in the Future of
Healthcare, Tech & Infrastructure

MedLinks Capital partners with exceptional companies and projects across high-growth sectors. We connect private capital with differentiated opportunities and provide the strategic relationships and expertise to accelerate long-term value creation.

Scroll
$5B+
Value Created
30+
Portfolio Companies
40
Years of Expertise
4
Continents Active
+
"We don't just invest capital — we invest conviction, strategy, and decades of deep domain expertise."
Gurdev Chimni, CEO
Private Capital
Health
Technology
Infrastructure
Who We Are

A Different Kind of
Capital Partner

MedLinks Capital is a private investment and strategic capital firm focused on opportunities across health, technology, and infrastructure. We combine private capital, strategic relationships, and hands-on partnership to help exceptional companies and projects scale and create long-term value.

Partnership-Driven Approach
We work alongside founders, operators, and management teams, providing strategic support beyond capital.
Deep Domain Expertise
Experience and insight across healthcare, technology, digital infrastructure, and real assets.
Global Strategic Network
Access to a global network of investors, institutions, industry leaders, and strategic partners.
Portfolio

Investments

View All Portfolio
Digital Infrastructure
483-acre hyperscale data center campus along Georgia's I-20 corridor, supporting up to 1.4 GW of power capacity for hyperscale and AI-driven compute. Adjacent to Meta's data center and Rivian's 16M sq. ft. campus. Targeting a ~$4B NASDAQ IPO.
Current2026
Biopharmaceuticals
Clinical-stage biotech advancing personalised cancer immunotherapy. FDA RMAT-designated, Phase 3-ready platform leveraging genetic and cellular technologies to enhance immune response against tumours.
Current2021
Medical Devices
Pioneering robotic surgical technologies enabling complex procedures through smaller access points with greater precision. FDA Breakthrough Device designation, redefining the standard for minimally invasive surgery.
Current2022
Investment Focus

Areas of Deep Expertise

All Focus Areas
Health
Healthcare, life sciences, biotechnology, medical technology, and innovative care platforms.
Learn More
Technology
Artificial intelligence, digital platforms, enterprise technology, and emerging technologies transforming industries.
Learn More
Infrastructure
Data centers, digital infrastructure, energy, power, and mission-critical real assets.
Learn More
News & Insights

Latest from MedLinks

All Insights
Industry Insight
From KCI to Gradalis: A Legacy of Healthcare Value Creation
How decades of building category-defining companies — a 12,882x MOIC on KCI, $4B Fresenius exit on Renal Care Group — inform our approach to today's breakthrough pipeline.
April 20266 min read
Read Full Story